Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502434 · ClinicalTrials.gov registry record · Phase 1
A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers
A Phase 1 study, sponsored by Biosplice Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 223
- Enrollment target
NCT03502434: Completed Phase 1 study, sponsored by Biosplice Therapeutics.
NCT03502434 is a Phase 1 study that has completed, run by Biosplice Therapeutics. The registered enrollment target is 223 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (272% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03502434, a Phase 1 study, has completed, sponsored by Biosplice Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 223 participants
- Enrollment target
Study Summary
This is a single center, randomized, controlled, within subject comparison, single dose study to determine the sensitization potential of SM04755 solution on normal skin under semi-occlusive patch conditions.
Interventions
- OTHER Vehicle
- OTHER Sodium lauryl sulfate
- OTHER White Petrolatum
- DRUG SM04755
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2017-11-17 |
| Phase | Phase 1 |
What the finished NCT03502434 record still lists
NCT03502434 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (272% higher).
The record links to 0 conditions, and to 4 interventions - of which Vehicle is the first listed.
NCT03502434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03502434 about?
NCT03502434 is a clinical study titled "A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers". This is a single center, randomized, controlled, within subject comparison, single dose study to determine the sensitization potential of SM04755 solution on normal skin under semi-occlusive patch conditions.
What is the current status of trial NCT03502434?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 223 participants. The study started on 2017-09-11. Estimated completion is 2017-11-17.
What interventions are being tested in trial NCT03502434?
The interventions under investigation include: Vehicle (OTHER), Sodium lauryl sulfate (OTHER), White Petrolatum (OTHER), SM04755 (DRUG).
Who is sponsoring clinical trial NCT03502434?
This trial is sponsored by Biosplice Therapeutics, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03502434's enrollment target sits among peer trials
223 228th of 2000 higher than 1,772 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI